Conviction Life Sciences (LSE:CLSC) - Stock Price, News & Analysis

CLSC Stock Overview

Conviction Life Sciences Company Limited focuses on investing in publicly traded and private life sciences and medical technology businesses in the United Kingdom, Europe, and Australasia. More details

CLSC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap (£0)

Shares are highly illiquid

Has not reported any financial data

Conviction Life Sciences Company Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Conviction Life Sciences
Historical stock prices
Current Share Price	UK£1.00
52 Week High	UK£0
52 Week Low	UK£0
Beta	0
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent updates

Shareholder Returns

	CLSC	GB Biotechs	GB Market
7D	n/a	-5.2%	1.0%
1Y	n/a	-19.8%	6.3%

Return vs Industry: Insufficient data to determine how CLSC performed against the UK Biotechs industry.

Return vs Market: Insufficient data to determine how CLSC performed against the UK Market.

Price Volatility

Is CLSC's price volatile compared to industry and market?
CLSC volatility
CLSC Average Weekly Movement	n/a
Biotechs Industry Average Movement	9.6%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.2%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: CLSC has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine CLSC's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2022	n/a	n/a	www.clsc.uk

Conviction Life Sciences Company Limited Fundamentals Summary

How do Conviction Life Sciences's earnings and revenue compare to its market cap?
CLSC fundamental statistics
Market cap	n/a
Earnings (TTM)	UK£0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is CLSC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CLSC income statement (TTM)
Revenue	UK£0
Cost of Revenue	UK£0
Gross Profit	UK£0
Other Expenses	UK£0
Earnings	UK£0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did CLSC perform over the long term?

See historical performance and comparison

Conviction Life Sciences LSE:CLSC Stock Report